Telo Genomics Corp. (TELO.V)
CAD 0.12
(0.0%)
CAD 0.12
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.45 Million | -2.62 Million | -1.79 Million | -1.1 Million | -1.11 Million | -327.83 Thousand |
| Net Income | -2.71 Million | -2.82 Million | -2.11 Million | -1.06 Million | -1.24 Million | -1.07 Million |
| Depreciation & Amortization | 39.53 Thousand | 33.11 Thousand | 56.95 Thousand | 62.22 Thousand | 64.71 Thousand | 82.9 Thousand |
| Deferred income taxes | - | -252.18 Thousand | -206.56 Thousand | -3750.00 | - | - |
| Stock-based compensation | - | 160.16 Thousand | 151.4 Thousand | 141.55 Thousand | 359.5 Thousand | 43.35 Thousand |
| Change in working capital | 158.15 Thousand | -2069.00 | 107.09 Thousand | -51.11 Thousand | -206.38 Thousand | 320.09 Thousand |
| Other non-cash items | 56.15 Thousand | 252.18 Thousand | 206.56 Thousand | -183.48 Thousand | -95.69 Thousand | 300 Thousand |
| Investing Cash Flow | -5115.00 | -69.06 Thousand | -25.19 Thousand | -9310.00 | -8671.00 | - |
| Investments in PPE | -5116.00 | -69.06 Thousand | -25.19 Thousand | -9310.00 | -8671.00 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -69.06 Thousand | - | - | - | - |
| Financing Cash Flow | 587.05 Thousand | 2.67 Million | 876.64 Thousand | 3.82 Million | 2.02 Million | 280 Thousand |
| Debt repayment | - | -7500.00 | - | -15 Thousand | -350 Thousand | -280 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 609.55 Thousand | 2.83 Million | 195 Thousand | 2.09 Million | 1.73 Million | - |
| Other Financing Activities | -22.5 Thousand | -147.47 Thousand | 681.64 Thousand | 1.75 Million | 644.22 Thousand | 560 Thousand |
| Accounts receivables | 32.51 Thousand | -25.78 Thousand | 58.75 Thousand | -47.46 Thousand | -12.66 Thousand | 3932.00 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 125.64 Thousand | 23.71 Thousand | 48.34 Thousand | -3650.00 | -193.72 Thousand | 316.16 Thousand |
| Cash at beginning of period | 2.67 Million | 2.69 Million | 3.63 Million | 920.98 Thousand | 19.49 Thousand | 67.33 Thousand |
| Cash at end of period | 796.02 Thousand | 2.67 Million | 2.69 Million | 3.63 Million | 920.98 Thousand | 19.49 Thousand |
| Capital Expenditure | -5116.00 | -69.06 Thousand | -25.19 Thousand | -9310.00 | -8671.00 | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.87 Million | -19.71 Thousand | -943.53 Thousand | 2.71 Million | 901.48 Thousand | -47.83 Thousand |
| Free Cash Flow | -2.46 Million | -2.69 Million | -1.82 Million | -1.11 Million | -1.12 Million | -327.83 Thousand |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -599.25 Thousand | -606.06 Thousand | -835.14 Thousand | -672.54 Thousand | -854.87 Thousand | -2.82 Million |
| Depreciation & Amortization | 8812.00 | 9869.00 | 10.54 Thousand | 10.31 Thousand | 10.17 Thousand | 33.11 Thousand |
| Deferred income taxes | - | - | -89.46 Thousand | -61.34 Thousand | -89.84 Thousand | -252.18 Thousand |
| Stock-based compensation | - | - | 60.75 Thousand | 42.07 Thousand | 41.61 Thousand | 160.16 Thousand |
| Change in working capital | 124.32 Thousand | 24.42 Thousand | 79.62 Thousand | -70.21 Thousand | 130.85 Thousand | -2069.00 |
| Other non-cash items | -38.26 Thousand | -29.56 Thousand | 91.05 Thousand | 61.34 Thousand | 89.84 Thousand | 252.18 Thousand |
| Investing Cash Flow | -2315.00 | - | - | -2800.00 | -1009.00 | -69.06 Thousand |
| Investments in PPE | -2319.00 | 1.00 | - | -2800.00 | -1009.00 | -69.06 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 611.83 Thousand | -22.5 Thousand | - | -2282.00 | 2.61 Million | 2.67 Million |
| Debt repayment | - | - | - | - | - | -7500.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 611.83 Thousand | -2282.00 | 2282.00 | -2282.00 | 2.83 Million | 2.83 Million |
| Other Financing Activities | - | -20.21 Thousand | -2282.00 | -2282.00 | -214.97 Thousand | -147.47 Thousand |
| Accounts receivables | -515.00 | 39.3 Thousand | -7621.00 | 1349.00 | -27.88 Thousand | -25.78 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 124.83 Thousand | -14.87 Thousand | 87.24 Thousand | -71.56 Thousand | 158.73 Thousand | 23.71 Thousand |
| Cash at beginning of period | 690.88 Thousand | 1.29 Million | 1.97 Million | 2.67 Million | 727.57 Thousand | 2.69 Million |
| Cash at end of period | 796.02 Thousand | 690.88 Thousand | 1.29 Million | 1.97 Million | 2.67 Million | 2.67 Million |
| Capital Expenditure | -2319.00 | 1.00 | - | -2800.00 | -1009.00 | -69.06 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 105.13 Thousand | -604.27 Thousand | -682.62 Thousand | -695.46 Thousand | 1.94 Million | -19.71 Thousand |
| Free Cash Flow | -506.69 Thousand | -581.77 Thousand | -682.62 Thousand | -693.18 Thousand | -673.23 Thousand | -2.69 Million |
TECHM
GOR
VIVE
LFCR
JSWHL
0I1B